Case Study: Actinic Keratosis Phase III

Failure of sites to fulfill enrollment expectations on time often leads to major delays in clinical development programs. Novella Clinical was selected to conduct multiple large Phase III actinic keratosis studies, which involved from 60-960- patients in various sites in the United States. Novella’s patient recruitment services fulfilled enrollment goals up to 75% faster than sponsor-projected timelines and significantly reduced overall study spending. As a result, Novella was instrumental in assisting these sponsors with moving forward efficiently with their overall clinical development plans.